Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2440 participants
OBSERVATIONAL
2009-06-30
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary aim is to assess the positive and negative predictive values for a cardiovascular event of the three risk scores for chest pain patients.
Secondary aim is to assess the sensitivity and specificity of various elements in the patient history for an acute coronary syndrome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of the TIMI, GRACE, HEART and HEARTSIL Scores
NCT04661722
Pre-discharge vs. Early Post-discharge Stress Testing and GRACE Score for Safe Discharge of ACS-patients With a Negative Hs-troponin T Result
NCT02072538
Early Risk Stratification in ED Chest Pain Patients
NCT02364271
Predictive Value of Risk Scores in Acute Coronary Syndrome
NCT03549481
Impact on Management of the HEART Risk Score in Chest Pain Patients
NCT01756846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patient data during a follow up of at least 6 weeks are gathered from hospital charts.
The predictive value of the three scoring systems: HEART (History, ECG, Age, Risk factors, Troponin), TIMI (Thrombolysis in Myocardial Infarction) and GRACE (Global Registry of Acute Coronary Events) for both the discharge diagnosis and the occurrence of Major Adverse Cardiovascular Events (MACE) is calculated.
The primary hypothesis of the study is that the HEART score is a significantly better predictor than the TIMI and/or GRACE score for cardiovascular events during a six week period following admission to the emergency room.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Group
All included patients presented with chest pain at the emergency room within the inclusion period.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* concomitant non cardiac disease with expected fatal outcome within 1 year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Novartis
INDUSTRY
R&D Cardiologie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barbra Backus
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pieter Doevendans, MD,PhD,Prof
Role: STUDY_CHAIR
UMC Utrecht
Barbra Backus, MD
Role: PRINCIPAL_INVESTIGATOR
St Antionius Hospital Nieuwegein
Jacob Six, MD, PhD
Role: STUDY_DIRECTOR
Hofpoort Hospital Woerden
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meander Medical Centre
Amersfoort, , Netherlands
Gelre Hospital
Apeldoorn, , Netherlands
Reinier de Graaf Gasthuis
Delft, , Netherlands
University Medical Centre Groningen
Groningen, , Netherlands
Medical Centrum Haaglanden
Leidschendam, , Netherlands
St Antonius Hospital
Nieuwegein, , Netherlands
Medical Centre Haaglanden
The Hague, , Netherlands
St Antonius Hospital
Utrecht, , Netherlands
University Medical Centre Utrecht
Utrecht, , Netherlands
Hofpoort Hospital
Woerden, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Z-08.27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.